Oncolytic viruses: a novel form of immunotherapy
- 1 October 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 8 (10) , 1581-1588
- https://doi.org/10.1586/14737140.8.10.1581
Abstract
(2008). Oncolytic viruses: a novel form of immunotherapy. Expert Review of Anticancer Therapy: Vol. 8, No. 10, pp. 1581-1588.Keywords
This publication has 73 references indexed in Scilit:
- Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor ImmunityClinical Cancer Research, 2008
- Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumorsGene Therapy, 2008
- Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of ReovirusClinical Cancer Research, 2008
- Innate Recognition of VirusesImmunity, 2007
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunityClinical and Experimental Immunology, 2006
- Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyThe Journal of Experimental Medicine, 2006
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- Parvovirus H-1-Induced Tumor Cell Death Enhances Human Immune ResponseIn Vitrovia Increased Phagocytosis, Maturation, and Cross-Presentation by Dendritic CellsHuman Gene Therapy, 2005
- A listing of human tumor antigens recognized by T cells: March 2004 updateCancer Immunology, Immunotherapy, 2004